Literature DB >> 26740363

Higher physiopathogenicity by Fasciola gigantica than by the genetically close F. hepatica: experimental long-term follow-up of biochemical markers.

M Adela Valero1, M Dolores Bargues1, Messaoud Khoubbane1, Patricio Artigas1, Carla Quesada1, Lavinia Berinde2, Florencio M Ubeira3, Mercedes Mezo4, Jose L Hernandez5, Veronica H Agramunt1, Santiago Mas-Coma6.   

Abstract

BACKGROUND: Fascioliasis is caused by Fasciola hepatica and F. gigantica. The latter, always considered secondary in human infection, nowadays appears increasingly involved in Africa and Asia. Unfortunately, little is known about its pathogenicity, mainly due to difficulties in assessing the moment a patient first becomes infected and the differential diagnosis with F. hepatica.
METHODS: A long-term, 24-week, experimental study comparing F. hepatica and F. gigantica was made for the first time in the same animal model host, Guirra sheep. Serum biochemical parameters of liver damage, serum electrolytes, protein metabolism, plasma proteins, carbohydrate metabolism, hepatic lipid metabolism and inflammation were analysed on a biweekly basis as morbidity indicators. Serum anti-Fasciola IgG, coproantigen and egg shedding were simultaneously followed up.
RESULTS: rDNA and mtDNA sequencing and the morphometric study by computer image analysis system (CIAS) showed that fasciolids used fitted standard species characteristics. Results demonstrated that F. gigantica is more pathogenic, given its bigger size and biomass but not due to genetic differences which are few. Fasciola gigantica shows a delayed development of 1-2 weeks regarding both the biliary phase and the beginning of egg shedding, with respective consequences for biochemical modifications in the acute and chronic periods.
CONCLUSIONS: The higher F. gigantica pathogenicity contrasts with previous studies which only reflected the faster development of F. hepatica observed in short-term experiments.
© The Author 2015. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Biochemical parameters; Disease phases; Fasciola gigantica; Fasciola hepatica; Physiopathogenicity; Sheep

Mesh:

Substances:

Year:  2016        PMID: 26740363     DOI: 10.1093/trstmh/trv110

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  17 in total

Review 1.  Early Postnatal and Preschool-Age Infection by Fasciola spp.: Report of Five Cases from Vietnam and Worldwide Review.

Authors:  Nguyen Van De; Thanh Hoa Le; Veronica H Agramunt; Santiago Mas-Coma
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

2.  Rapid Enhanced MM3-COPRO ELISA for Detection of Fasciola Coproantigens.

Authors:  Victoria Martínez-Sernández; Ricardo A Orbegozo-Medina; Marta González-Warleta; Mercedes Mezo; Florencio M Ubeira
Journal:  PLoS Negl Trop Dis       Date:  2016-07-20

3.  Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins.

Authors:  Victoria Martínez-Sernández; María J Perteguer; Mercedes Mezo; Marta González-Warleta; Teresa Gárate; M Adela Valero; Florencio M Ubeira
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

4.  Seroprevalence of Fasciolagigantica infection in bovines using cysteine proteinase dot enzyme-linked immunosorbent assay.

Authors:  Niranjan Kumar; Anju Varghese; J B Solanki
Journal:  Vet World       Date:  2017-10-06

5.  Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.

Authors:  M Adela Valero; Ignacio Perez-Crespo; Carlos Chillón-Marinas; Messaoud Khoubbane; Carla Quesada; Marta Reguera-Gomez; Santiago Mas-Coma; Manuel Fresno; Núria Gironès
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

6.  DNA multigene characterization of Fasciola hepatica and Lymnaea neotropica and its fascioliasis transmission capacity in Uruguay, with historical correlation, human report review and infection risk analysis.

Authors:  María Dolores Bargues; Valeria Gayo; Jaime Sanchis; Patricio Artigas; Messaoud Khoubbane; Soledad Birriel; Santiago Mas-Coma
Journal:  PLoS Negl Trop Dis       Date:  2017-02-03

7.  Human Cases of Fascioliasis in Fujian Province, China.

Authors:  Lin Ai; Yu-Chun Cai; Yan Lu; Jia-Xu Chen; Shao-Hong Chen
Journal:  Korean J Parasitol       Date:  2017-02-28       Impact factor: 1.341

Review 8.  A prospective view of animal and human Fasciolosis.

Authors:  K Cwiklinski; S M O'Neill; S Donnelly; J P Dalton
Journal:  Parasite Immunol       Date:  2016-07-08       Impact factor: 2.280

9.  Molecular and Morphometrical Characterization of Fasciola Species Isolated from Domestic Ruminants in Ardabil Province, Northwestern Iran.

Authors:  Mojgan Aryaeipour; Arezoo Bozorgomid; Bahram Kazemi; Masoud Behnia; Hakim Azizi; Mohammad Bagher Rokni
Journal:  Iran J Public Health       Date:  2017-03       Impact factor: 1.429

10.  Numerous Fasciola plasminogen-binding proteins may underlie blood-brain barrier leakage and explain neurological disorder complexity and heterogeneity in the acute and chronic phases of human fascioliasis.

Authors:  J González-Miguel; M A Valero; M Reguera-Gomez; C Mas-Bargues; M D Bargues; F Simón; S Mas-Coma
Journal:  Parasitology       Date:  2018-09-24       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.